X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1027) 1027
Book Chapter (548) 548
Patent (158) 158
Newspaper Article (50) 50
Conference Proceeding (5) 5
Publication (5) 5
Book / eBook (4) 4
Dissertation (4) 4
Magazine Article (4) 4
Web Resource (2) 2
Book Review (1) 1
Reference (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (488) 488
life sciences & biomedicine (456) 456
humans (408) 408
oncology (360) 360
female (217) 217
male (206) 206
lung neoplasms - drug therapy (197) 197
middle aged (188) 188
aged (181) 181
carcinoma, non-small-cell lung - drug therapy (174) 174
lung neoplasms - genetics (164) 164
lung cancer (146) 146
adult (145) 145
carcinoma, non-small-cell lung - genetics (143) 143
chemistry (132) 132
biochemistry (131) 131
metallurgy (131) 131
microbiology (131) 131
beer (128) 128
enzymology (128) 128
mutation or genetic engineering (128) 128
spirits (128) 128
vinegar (128) 128
wine (128) 128
compositions or test papers therefor (126) 126
condition-responsive control in microbiological orenzymological processes (126) 126
measuring or testing processes involving enzymes, nucleicacids or microorganisms (126) 126
processes of preparing such compositions (126) 126
mutation (117) 117
lung neoplasms - pathology (116) 116
respiratory system (108) 108
cancer (99) 99
prognosis (97) 97
carcinoma, non-small-cell lung - pathology (89) 89
chemotherapy (88) 88
antineoplastic combined chemotherapy protocols - therapeutic use (85) 85
aged, 80 and over (77) 77
lung cancer, non-small cell (77) 77
treatment outcome (76) 76
lung neoplasms - mortality (70) 70
neoplasm staging (69) 69
genetic aspects (68) 68
antineoplastic agents - therapeutic use (67) 67
physics (67) 67
receptor, epidermal growth factor - genetics (64) 64
carcinoma, non-small-cell lung - mortality (62) 62
non-small cell lung cancer (61) 61
survival analysis (57) 57
care and treatment (54) 54
hematology, oncology and palliative medicine (53) 53
nsclc (49) 49
human necessities (48) 48
testing (48) 48
research (47) 47
investigating or analysing materials by determining theirchemical or physical properties (45) 45
measuring (45) 45
tumors (45) 45
pulmonary/respiratory (44) 44
review (44) 44
protein kinase inhibitors - therapeutic use (42) 42
survival rate (42) 42
cisplatin - administration & dosage (40) 40
hygiene (39) 39
medical or veterinary science (39) 39
health aspects (38) 38
non-small-cell lung cancer (38) 38
preparations for medical, dental, or toilet purposes (38) 38
general & internal medicine (37) 37
animals (36) 36
cancer therapies (36) 36
disease-free survival (36) 36
metastasis (36) 36
analysis (35) 35
lung neoplasms - metabolism (35) 35
pharmacology & pharmacy (35) 35
pulmonary and respiratory medicine (35) 35
gene expression (33) 33
medicine, research & experimental (33) 33
research & experimental medicine (33) 33
immunotherapy (32) 32
lung neoplasms - therapy (32) 32
medicine & public health (32) 32
dna repair (31) 31
non-small cell lung carcinoma (31) 31
retrospective studies (31) 31
cisplatin (30) 30
disease progression (30) 30
lung neoplasms - diagnosis (30) 30
patients (30) 30
respiratory tract diseases (30) 30
deoxycytidine - analogs & derivatives (29) 29
erlotinib (29) 29
neoplasms. tumors. oncology. including cancer and carcinogens (29) 29
drug resistance, neoplasm - genetics (28) 28
egfr (28) 28
erlotinib hydrochloride (28) 28
kinases (28) 28
medicine, general & internal (28) 28
receptor, epidermal growth factor - antagonists & inhibitors (28) 28
surgery (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1709) 1709
Spanish (95) 95
French (77) 77
German (47) 47
Portuguese (11) 11
Chinese (6) 6
Japanese (3) 3
Danish (2) 2
Greek (2) 2
Catalan (1) 1
Croatian (1) 1
Korean (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Translational lung cancer research, ISSN 2218-6751, 10/2016, Volume 5, Issue 5, pp. 557 - 560
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3138 - 3145
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S175 - S175
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1354 - 1356
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(15)01125-3 Byline: Rafael Rosell, Niki Karachaliou Author Affiliation... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - genetics | Female | Male | Gene Expression Profiling | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Genetic aspects | Diagnosis | Lung cancer | Cancer | Mutation | Kinases | Medical screening | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Nature genetics, ISSN 1546-1718, 02/2015, Volume 47, Issue 3, pp. 250 - 256
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Therapeutic advances in medical oncology, ISSN 1758-8359, 03/2018, Volume 10, pp. 175883591876462 - 1758835918764628
Immunotherapy through checkpoint inhibitors is now standard practice for a growing number of cancer types, supported by overall improvement of clinical... 
anti-PD-L1 | toxicity | corticosteroids | immune-related adverse events | immunotherapy | immunosuppression | immune checkpoint inhibitors | anti-CTLA-4 | anti-PD-1 | Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article